Objective: To establish a rapid testing method for genogroup Ⅱ (GⅡ) norovirus based on reverse transcription loop-mediated isothermal amplification (RT-LAMP).
Methods: The conserved region of norovirus was screened using the genomic data from the National Center for Biotechnology Information (NCBI) database, and specific primers were designed using the online software Primer Explorer V5. The testing system was established through optimization of experimental conditions, including reaction temperature, MgSO4 concentration, dNTP concentration, etc. The sensitivity and specificity of the method were evaluated. The optimized testing method was used to analyze clinical stool samples, and the results were compared with those of a commercially available kit.
Results: The established testing method exhibited high specificity, showing no cross-reactivity with adenovirus, human enterovirus, or rotavirus. The testing method also exhibited high sensitivity, with a detection limit of 51 copies/μL. The turnaround time was 45 min. For 34 stool samples from patients infected with norovirus, the testing results were highly consistent with those of the commercial kit, with a sensitivity of 100%, a specificity of 83.33%, and an area under the receiver operating characteristic (ROC) curve of 0.97 (95% CI: 0.92-1.00), indicating the high accuracy and reliability of the testing method.
Conclusion: In this study, we successfully developed an RT-LAMP-based testing method for GⅡ norovirus, which exhibits excellent sensitivity, specificity, and practical performance in clinical sample testing, making it suitable for use in primary care laboratories and for rapid testing in field settings.
目的:建立一种基于逆转录环介导等温扩增(RT-LAMP)的基因群Ⅱ(GⅡ)诺如病毒快速检测方法。方法:利用美国国家生物技术信息中心(National Center for Biotechnology Information, NCBI)数据库的基因组数据筛选诺如病毒的保守区,利用Primer Explorer V5软件设计特异性引物。通过优化实验条件,包括反应温度、MgSO4浓度、dNTP浓度等,建立了测试系统。评价了该方法的敏感性和特异性。采用优化后的检测方法对临床粪便样本进行分析,并与市售试剂盒的结果进行比较。结果:所建立的检测方法特异性高,与腺病毒、人肠道病毒、轮状病毒无交叉反应。检测限为51个拷贝/μL,灵敏度较高。周转时间为45分钟。34例诺如病毒感染患者粪便标本的检测结果与市售试剂盒的检测结果高度一致,灵敏度为100%,特异性为83.33%,受试者工作特征(ROC)曲线下面积为0.97 (95% CI: 0.92-1.00),表明该检测方法具有较高的准确性和可靠性。结论:在本研究中,我们成功开发了一种基于rt - lamp的GⅡ诺如病毒检测方法,该方法在临床样品检测中具有良好的灵敏度、特异性和实用性,适用于初级保健实验室和现场快速检测。
{"title":"[Development of a Reverse Transcription Loop-Mediated Isothermal Amplification Assay for the Detection of Genogroup Ⅱ Norovirus].","authors":"Yi Liu, Jing Zhang, Chao Zhao, Juan Wang","doi":"10.12182/20251160201","DOIUrl":"10.12182/20251160201","url":null,"abstract":"<p><strong>Objective: </strong>To establish a rapid testing method for genogroup Ⅱ (GⅡ) norovirus based on reverse transcription loop-mediated isothermal amplification (RT-LAMP).</p><p><strong>Methods: </strong>The conserved region of norovirus was screened using the genomic data from the National Center for Biotechnology Information (NCBI) database, and specific primers were designed using the online software Primer Explorer V5. The testing system was established through optimization of experimental conditions, including reaction temperature, MgSO<sub>4</sub> concentration, dNTP concentration, etc. The sensitivity and specificity of the method were evaluated. The optimized testing method was used to analyze clinical stool samples, and the results were compared with those of a commercially available kit.</p><p><strong>Results: </strong>The established testing method exhibited high specificity, showing no cross-reactivity with adenovirus, human enterovirus, or rotavirus. The testing method also exhibited high sensitivity, with a detection limit of 51 copies/μL. The turnaround time was 45 min. For 34 stool samples from patients infected with norovirus, the testing results were highly consistent with those of the commercial kit, with a sensitivity of 100%, a specificity of 83.33%, and an area under the receiver operating characteristic (ROC) curve of 0.97 (95% CI: 0.92-1.00), indicating the high accuracy and reliability of the testing method.</p><p><strong>Conclusion: </strong>In this study, we successfully developed an RT-LAMP-based testing method for GⅡ norovirus, which exhibits excellent sensitivity, specificity, and practical performance in clinical sample testing, making it suitable for use in primary care laboratories and for rapid testing in field settings.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1691-1696"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796918/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To investigate the molecular mechanisms of immune cells (ICs)- and senescence-related biomarkers in atrial fibrillation (AF).
Methods: In this study, immune cell-related genes (ICRGs) were obtained using weighted gene co-expression network analysis (WGCNA) based on the GSE2240 dataset. Subsequently, the intersection of ICRGs, senescence-related genes (SRGs), and differentially expressed genes (DEGs) derived from differential expression analysis between AF and sinus rhythm (SR) groups was obtained to screen candidate genes. Biomarkers were further identified using the least absolute shrinkage and selection operator (LASSO) algorithm and validated in the GSE115571 dataset. Gene set enrichment analysis (GSEA), GeneMANIA network construction, molecular regulatory network construction, and molecular docking were performed to investigate the molecular mechanisms of the biomarkers in AF. A total of 8 male Sprague-Dawley rats of 87 weeks old and weighing 632-656 g were randomly assigned to the AF group and the sinus rhythm (SR) group (n = 4 per group). An AF rat model was established. The mRNA expression levels of myosin light chain kinase (MYLK) and insulin-like growth factor binding protein 2 (IGFBP2) in rat myocardial tissue were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR).
Results: Two biomarkers, MYLK and IGFBP2, were identified. GSEA revealed that MYLK was significantly enriched in the olfactory transduction pathway, whereas IGFBP2 was significantly enriched in the extracellular matrix-receptor interaction pathway. The GeneMANIA network demonstrated functional similarity between these biomarkers and 20 other genes. In addition, MYLK was regulated by 28 transcription factors (TFs) and 41 microRNAs (miRNAs), whereas IGFBP2 was regulated by 63 TFs and 4 miRNAs, including TAF1 and MIRT020526. Drug prediction analysis indicated that only MYLK had potential interactions with 3 drugs, among which Tozasertib exhibited the strongest binding affinity to MYLK, with a binding energy of -7.8 kcal/mol. RT-qPCR results showed that IGFBP2 mRNA expression was upregulated and MYLK mRNA expression was downregulated in myocardial tissue of rats in the AF group compared with the SR group (both P < 0.05).
Conclusion: In this study, MYLK and IGFBP2 are identified as AF-related biomarkers, and their potential molecular mechanisms are elucidated, providing new theoretical insights into AF research.
{"title":"[Identification and Underlying Mechanisms of Immune Cell- and Senescence-Related Biomarkers in Atrial Fibrillation].","authors":"Wei Huang, Enzhao Liu, Huaying Fu","doi":"10.12182/20251160108","DOIUrl":"10.12182/20251160108","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the molecular mechanisms of immune cells (ICs)- and senescence-related biomarkers in atrial fibrillation (AF).</p><p><strong>Methods: </strong>In this study, immune cell-related genes (ICRGs) were obtained using weighted gene co-expression network analysis (WGCNA) based on the GSE2240 dataset. Subsequently, the intersection of ICRGs, senescence-related genes (SRGs), and differentially expressed genes (DEGs) derived from differential expression analysis between AF and sinus rhythm (SR) groups was obtained to screen candidate genes. Biomarkers were further identified using the least absolute shrinkage and selection operator (LASSO) algorithm and validated in the GSE115571 dataset. Gene set enrichment analysis (GSEA), GeneMANIA network construction, molecular regulatory network construction, and molecular docking were performed to investigate the molecular mechanisms of the biomarkers in AF. A total of 8 male Sprague-Dawley rats of 87 weeks old and weighing 632-656 g were randomly assigned to the AF group and the sinus rhythm (SR) group (<i>n</i> = 4 per group). An AF rat model was established. The mRNA expression levels of myosin light chain kinase (MYLK) and insulin-like growth factor binding protein 2 (IGFBP2) in rat myocardial tissue were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR).</p><p><strong>Results: </strong>Two biomarkers, MYLK and IGFBP2, were identified. GSEA revealed that MYLK was significantly enriched in the olfactory transduction pathway, whereas IGFBP2 was significantly enriched in the extracellular matrix-receptor interaction pathway. The GeneMANIA network demonstrated functional similarity between these biomarkers and 20 other genes. In addition, MYLK was regulated by 28 transcription factors (TFs) and 41 microRNAs (miRNAs), whereas IGFBP2 was regulated by 63 TFs and 4 miRNAs, including TAF1 and MIRT020526. Drug prediction analysis indicated that only MYLK had potential interactions with 3 drugs, among which Tozasertib exhibited the strongest binding affinity to MYLK, with a binding energy of -7.8 kcal/mol. RT-qPCR results showed that <i>IGFBP2</i> mRNA expression was upregulated and <i>MYLK</i> mRNA expression was downregulated in myocardial tissue of rats in the AF group compared with the SR group (both <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>In this study, MYLK and IGFBP2 are identified as AF-related biomarkers, and their potential molecular mechanisms are elucidated, providing new theoretical insights into AF research.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1612-1619"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145970996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Regulatory T cells (Tregs) are the most important population of immune cells in maintaining peripheral immune tolerance in the body. Targeting Tregs to rebuild peripheral immune tolerance has shown broad potential for application in the treatment of various inflammatory diseases, such as autoimmune diseases, allergic disorders, graft-versus-host disease, and organ transplant rejection. However, substantial challenges remain in translating Treg-based therapies into clinical practice. In this review, we first summarize the discovery of Tregs and the principal mechanisms through which Tregs inhibit immune responses. Then, the research progress in polyclonal Treg-based therapy, antigen-specific Treg-based therapy, and low-dose interleukin-2 (IL-2) therapy and the implementation status of clinical trials of Treg therapies were comprehensively summarized. Finally, four issues, including maintaining the stability of Tregs, preparing autoantigen-specific Tregs, such as chimeric antigen receptor (CAR)-Tregs and T-cell receptor (TCR)-Tregs, reshaping the inflammatory microenvironment of diseases, and minimizing the potential adverse effects of Treg therapies, were highlighted as the bottleneck problems in the clinical translation of Treg therapies and priority directions for future research.
调节性T细胞(Regulatory T cells, Tregs)是维持机体外周免疫耐受最重要的免疫细胞群。靶向Tregs重建外周免疫耐受在治疗各种炎症性疾病,如自身免疫性疾病、过敏性疾病、移植物抗宿主病和器官移植排斥反应等方面显示出广泛的应用潜力。然而,将treg为基础的治疗方法转化为临床实践仍然存在重大挑战。在这篇综述中,我们首先总结了Tregs的发现和Tregs抑制免疫反应的主要机制。然后,对Treg多克隆治疗、抗原特异性Treg治疗、低剂量白介素-2 (IL-2)治疗的研究进展及Treg治疗的临床试验实施情况进行了全面总结。最后,强调了维持Treg的稳定性、制备自身抗原特异性Treg,如嵌合抗原受体(CAR)-Tregs和t细胞受体(TCR)-Tregs、重塑疾病炎症微环境、减少Treg治疗的潜在不良反应等4个问题是Treg治疗临床转化的瓶颈问题和未来研究的重点方向。
{"title":"[Targeting Regulatory T Cells to Remodel Peripheral Immune Tolerance: Research Advances and Future Directions].","authors":"Wei Zhang, Zhenhong Li, Hantian Liang, Hao Cheng, Dunfang Zhang","doi":"10.12182/20251160301","DOIUrl":"10.12182/20251160301","url":null,"abstract":"<p><p>Regulatory T cells (Tregs) are the most important population of immune cells in maintaining peripheral immune tolerance in the body. Targeting Tregs to rebuild peripheral immune tolerance has shown broad potential for application in the treatment of various inflammatory diseases, such as autoimmune diseases, allergic disorders, graft-versus-host disease, and organ transplant rejection. However, substantial challenges remain in translating Treg-based therapies into clinical practice. In this review, we first summarize the discovery of Tregs and the principal mechanisms through which Tregs inhibit immune responses. Then, the research progress in polyclonal Treg-based therapy, antigen-specific Treg-based therapy, and low-dose interleukin-2 (IL-2) therapy and the implementation status of clinical trials of Treg therapies were comprehensively summarized. Finally, four issues, including maintaining the stability of Tregs, preparing autoantigen-specific Tregs, such as chimeric antigen receptor (CAR)-Tregs and T-cell receptor (TCR)-Tregs, reshaping the inflammatory microenvironment of diseases, and minimizing the potential adverse effects of Treg therapies, were highlighted as the bottleneck problems in the clinical translation of Treg therapies and priority directions for future research.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1459-1466"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Objective: </strong>To investigate the association between the disease severity and prognosis of cerebral infarction patients and serum levels of neuron-specific enolase (NSE), angiopoietin-1 (Ang-1), and angiopoietin-like protein-3 (ANGPTL3).</p><p><strong>Methods: </strong>A total of 510 patients with cerebral infarction admitted to the Department of Neurology, the First People's Hospital of Jiujiang City, Jiangxi Province between February 2022 and May 2024 were enrolled. According to their disease severity, the patients were divided into a mild group (<i>n</i> = 192), a moderate group (<i>n</i> = 215), and a severe group (<i>n</i> = 103). After treatment, the patients were further divided into a good prognosis group (<i>n</i> = 384) and a poor prognosis group (<i>n</i> = 126). During the same period, 121 healthy individuals were included as a control group. During the same period, 121 healthy individuals were included in a control group. Serum levels of NSE, Ang-1, and ANGPTL3 of all patients were measured upon admission. The correlations between these biomarkers and disease severity were analyzed. The predictive value of each biomarker alone and that of the 3 biomarkers in combination for poor prognosis in patients with cerebral infarction were assessed using receiver operating characteristic (ROC) curves.</p><p><strong>Results: </strong>Serum NSE and ANGPTL3 levels in the severe group were significantly higher than those in the moderate and mild groups, whereas the serum Ang-1 levels in the severe group were significantly lower than those in the moderate and mild groups (all <i>P</i> < 0.05). Spearman correlation analysis showed that serum NSE and ANGPTL3 levels were positively correlated with disease severity (<i>r</i> = 0.179 and 0.313, respectively, <i>P</i> < 0.05), while serum Ang-1 levels were negatively correlated with disease severity (<i>r</i> = -0.187, <i>P</i> < 0.05). Prognostic analysis revealed that serum NSE and ANGPTL3 levels were higher, while serum Ang-1 levels were lower, in the poor prognosis group compared with the good prognosis group (all <i>P</i> < 0.05). Multivariate logistic regression revealed that serum levels of NSE (odds ratio [OR] = 1.228, 95% CI: 1.146-1.316), Ang-1 (OR = 0.059, 95% CI: 0.020-0.178), and ANGPTL3 (OR = 1.334, 95% CI: 1.256-1.417) were major factors associated with prognosis in patients with cerebral infarction (all <i>P</i> < 0.05). ROC curves showed that serum NSE, Ang-1, and ANGPTL3 levels in combination yielded an area under the curve (AUC) of 0.904 (95% CI: 0.871-0.936), with a sensitivity of 79.40% and a specificity of 89.60%. The Hosmer-Lemeshow test of the model showed a good predictive performance (<i>χ</i> <sup>2</sup> = 7.423, <i>P</i> = 0.492).</p><p><strong>Conclusion: </strong>The severity and prognosis of cerebral infarction patients are strongly correlated with high serum NSE and ANGPTL3 levels and low Ang-1 levels. Monitoring changes in these 3 biomarkers may inform c
{"title":"[Correlation of Serum Neuron-Specific Enolase, Angiopoietin-1, and Angiopoietin-Like Protein-3 With Disease Severity and Their Prognostic Value in Patients With Cerebral Infarction].","authors":"Jianping Liu, Hui Gao, Yufan Liu","doi":"10.12182/20251160506","DOIUrl":"10.12182/20251160506","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the association between the disease severity and prognosis of cerebral infarction patients and serum levels of neuron-specific enolase (NSE), angiopoietin-1 (Ang-1), and angiopoietin-like protein-3 (ANGPTL3).</p><p><strong>Methods: </strong>A total of 510 patients with cerebral infarction admitted to the Department of Neurology, the First People's Hospital of Jiujiang City, Jiangxi Province between February 2022 and May 2024 were enrolled. According to their disease severity, the patients were divided into a mild group (<i>n</i> = 192), a moderate group (<i>n</i> = 215), and a severe group (<i>n</i> = 103). After treatment, the patients were further divided into a good prognosis group (<i>n</i> = 384) and a poor prognosis group (<i>n</i> = 126). During the same period, 121 healthy individuals were included as a control group. During the same period, 121 healthy individuals were included in a control group. Serum levels of NSE, Ang-1, and ANGPTL3 of all patients were measured upon admission. The correlations between these biomarkers and disease severity were analyzed. The predictive value of each biomarker alone and that of the 3 biomarkers in combination for poor prognosis in patients with cerebral infarction were assessed using receiver operating characteristic (ROC) curves.</p><p><strong>Results: </strong>Serum NSE and ANGPTL3 levels in the severe group were significantly higher than those in the moderate and mild groups, whereas the serum Ang-1 levels in the severe group were significantly lower than those in the moderate and mild groups (all <i>P</i> < 0.05). Spearman correlation analysis showed that serum NSE and ANGPTL3 levels were positively correlated with disease severity (<i>r</i> = 0.179 and 0.313, respectively, <i>P</i> < 0.05), while serum Ang-1 levels were negatively correlated with disease severity (<i>r</i> = -0.187, <i>P</i> < 0.05). Prognostic analysis revealed that serum NSE and ANGPTL3 levels were higher, while serum Ang-1 levels were lower, in the poor prognosis group compared with the good prognosis group (all <i>P</i> < 0.05). Multivariate logistic regression revealed that serum levels of NSE (odds ratio [OR] = 1.228, 95% CI: 1.146-1.316), Ang-1 (OR = 0.059, 95% CI: 0.020-0.178), and ANGPTL3 (OR = 1.334, 95% CI: 1.256-1.417) were major factors associated with prognosis in patients with cerebral infarction (all <i>P</i> < 0.05). ROC curves showed that serum NSE, Ang-1, and ANGPTL3 levels in combination yielded an area under the curve (AUC) of 0.904 (95% CI: 0.871-0.936), with a sensitivity of 79.40% and a specificity of 89.60%. The Hosmer-Lemeshow test of the model showed a good predictive performance (<i>χ</i> <sup>2</sup> = 7.423, <i>P</i> = 0.492).</p><p><strong>Conclusion: </strong>The severity and prognosis of cerebral infarction patients are strongly correlated with high serum NSE and ANGPTL3 levels and low Ang-1 levels. Monitoring changes in these 3 biomarkers may inform c","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1647-1652"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Myopia is a global public health challenge. It is projected that the myopia rate in China will reach 80% by 2050, which will cause visual impairment, psychological problems, and economic burdens. The effective prevention and control of myopia are critical for improving the health of children and adolescents and reducing socioeconomic burdens. The existing myopia prevention and control strategies include individual interventions and school-based group interventions, which have shown remarkable results. However, limitations such as insufficient compliance, high technical costs, and regional differences have limited their effects. The policy-advocated five-in-one prevention and control system (consisting of the government, schools, families, health care, and society) faces challenges in effectively integrating multi-field strategies due to poor interdepartmental coordination, uneven resource distribution, and the lack of assessment mechanisms. Through a systematic literature review, this paper examines research on myopia prevention and control across multiple fields such as medicine, education, technology, and policy. Based on the micro, meso, and macro perspectives of the Social Ecological Systems Theory (SET), the advantages and limitations of strategies are analyzed, and optimization pathways are explored.
{"title":"[Optimization of Comprehensive Prevention and Control Strategies for Myopia From the Persepctive of the Social Ecological Systems Theory].","authors":"Zewei Chen, Mengrong Zhu, Lin Yue","doi":"10.12182/20251160601","DOIUrl":"10.12182/20251160601","url":null,"abstract":"<p><p>Myopia is a global public health challenge. It is projected that the myopia rate in China will reach 80% by 2050, which will cause visual impairment, psychological problems, and economic burdens. The effective prevention and control of myopia are critical for improving the health of children and adolescents and reducing socioeconomic burdens. The existing myopia prevention and control strategies include individual interventions and school-based group interventions, which have shown remarkable results. However, limitations such as insufficient compliance, high technical costs, and regional differences have limited their effects. The policy-advocated five-in-one prevention and control system (consisting of the government, schools, families, health care, and society) faces challenges in effectively integrating multi-field strategies due to poor interdepartmental coordination, uneven resource distribution, and the lack of assessment mechanisms. Through a systematic literature review, this paper examines research on myopia prevention and control across multiple fields such as medicine, education, technology, and policy. Based on the micro, meso, and macro perspectives of the Social Ecological Systems Theory (SET), the advantages and limitations of strategies are analyzed, and optimization pathways are explored.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1506-1512"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To establish and validate a risk prediction model for mechanical ventilator-associated pneumonia (VAP) in older patients with lung cancer.
Methods: A total of 548 older patients with lung cancer were enrolled between January 2022 and May 2025. Subsequently, the patients were divided into a training set (n = 384) and a validation set (n = 164) at a ratio of 7∶3. According to whether the patients developed VAP, the training set was further divided into a non-VAP subgroup (n = 231) and a VAP subgroup (n = 153), and the validation set was divided into a non-VAP subgroup (n = 99) and a VAP subgroup (n = 65). Multivariate stepwise logistic regression was conducted to identify the predictors of VAP in older patients with lung cancer, and a nomogram model was established accordingly. The model was validated using the receiver operating characteristic (ROC) curve and the calibration curve.
Results: A total of 153 participants (39.84%) in the training set and 65 participants (39.63%) in the validation set developed VAP. Univariate analysis revealed that such factors as age, lung cancer stage, mechanical ventilation duration, Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) Ⅱ score, procalcitonin (PCT), pentraxin 3 (PTX3), retinol-binding protein (RBP), soluble triggering receptor expressed on myeloid cells-1 (STREM-1), and human cartilage glycoprotein-39 (YKL-40) were associated with VAP in older lung cancer patients (P < 0.05), and there was no multicollinearity. Multivariate logistic stepwise regression revealed that age (odds ratio [OR] = 1.182, 95% CI: 1.014-1.377), mechanical ventilation duration (OR = 3.929, 95% CI: 1.374-11.233), APACHE Ⅱ (OR = 1.770, 95% CI: 1.296-2.416), PTX3 (OR = 1.019, 95% CI: 1.007-1.030), RBP (OR = 1.150, 95% CI: 1.083-1.260), STREM-1 (OR = 1.168, 95% CI: 1.083-1.260) were predictors of VAP in older lung cancer patients (P < 0.05). A nomogram model was constructed with the following equation: Prob = 1/(1 + e-Y), Y = -43.147 + 0.167 × age + 1.368× mechanical ventilation duration + 0.571 × APACHE Ⅱ score + 0.019 × PTX3 + 0.140 × RBP + 0.155 × STREM-1. The area under the curve (AUC) of the ROC in the training set was 0.909 (95% CI: 0.878-0.940), and the AUC of the validation set was 0.843 (95% CI: 0.776-0.910). The average absolute error tested by the Bootstrap method was 0.03, indicating that the model showed a certain level of consistency during both the training and validation processes.
Conclusion: Age, mechanical ventilation duration, APACHE Ⅱ score, and serum levels of PTX3, RBP, and STREM-1 are all predictors for the occurrence of VAP in older lung cancer patients. The nomogram model constructed based on these factors demonstrates acceptable predictive performance.
{"title":"[Construction and Clinical Validation of a Risk Early Warning Model for Mechanical Ventilation-Associated Pneumonia in Older Patients With Lung Cancer].","authors":"Zhiyan Wang, Min Shi, Peng Zhao, Yu Zhou, Zhijian Zhang, Geping Qu, Xiangqun Fang","doi":"10.12182/20251160205","DOIUrl":"10.12182/20251160205","url":null,"abstract":"<p><strong>Objective: </strong>To establish and validate a risk prediction model for mechanical ventilator-associated pneumonia (VAP) in older patients with lung cancer.</p><p><strong>Methods: </strong>A total of 548 older patients with lung cancer were enrolled between January 2022 and May 2025. Subsequently, the patients were divided into a training set (<i>n</i> = 384) and a validation set (<i>n</i> = 164) at a ratio of 7∶3. According to whether the patients developed VAP, the training set was further divided into a non-VAP subgroup (<i>n</i> = 231) and a VAP subgroup (<i>n</i> = 153), and the validation set was divided into a non-VAP subgroup (<i>n</i> = 99) and a VAP subgroup (<i>n</i> = 65). Multivariate stepwise logistic regression was conducted to identify the predictors of VAP in older patients with lung cancer, and a nomogram model was established accordingly. The model was validated using the receiver operating characteristic (ROC) curve and the calibration curve.</p><p><strong>Results: </strong>A total of 153 participants (39.84%) in the training set and 65 participants (39.63%) in the validation set developed VAP. Univariate analysis revealed that such factors as age, lung cancer stage, mechanical ventilation duration, Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) Ⅱ score, procalcitonin (PCT), pentraxin 3 (PTX3), retinol-binding protein (RBP), soluble triggering receptor expressed on myeloid cells-1 (STREM-1), and human cartilage glycoprotein-39 (YKL-40) were associated with VAP in older lung cancer patients (<i>P</i> < 0.05), and there was no multicollinearity. Multivariate logistic stepwise regression revealed that age (odds ratio [OR] = 1.182, 95% CI: 1.014-1.377), mechanical ventilation duration (OR = 3.929, 95% CI: 1.374-11.233), APACHE Ⅱ (OR = 1.770, 95% CI: 1.296-2.416), PTX3 (OR = 1.019, 95% CI: 1.007-1.030), RBP (OR = 1.150, 95% CI: 1.083-1.260), STREM-1 (OR = 1.168, 95% CI: 1.083-1.260) were predictors of VAP in older lung cancer patients (<i>P</i> < 0.05). A nomogram model was constructed with the following equation: Prob = 1/(1 + e<sup>-Y</sup>), Y = -43.147 + 0.167 × age + 1.368× mechanical ventilation duration + 0.571 × APACHE Ⅱ score + 0.019 × PTX3 + 0.140 × RBP + 0.155 × STREM-1. The area under the curve (AUC) of the ROC in the training set was 0.909 (95% CI: 0.878-0.940), and the AUC of the validation set was 0.843 (95% CI: 0.776-0.910). The average absolute error tested by the Bootstrap method was 0.03, indicating that the model showed a certain level of consistency during both the training and validation processes.</p><p><strong>Conclusion: </strong>Age, mechanical ventilation duration, APACHE Ⅱ score, and serum levels of PTX3, RBP, and STREM-1 are all predictors for the occurrence of VAP in older lung cancer patients. The nomogram model constructed based on these factors demonstrates acceptable predictive performance.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1620-1626"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Objective: </strong>To investigate the changes in knowledge, attitude, and practice (KAP) regarding the integration of medical care and prevention among medical professionals in medical institutions of pilot cities of the collaboration and integration of medical care and prevention, a national pilot program for infectious disease prevention and control, to examine the effect pathways, and to provide empirical evidence for promoting the implementation of the integration of medical care and prevention and improving relevant policies.</p><p><strong>Methods: </strong>The participants in this study were medical professionals involved in medical care and prevention integration work. The participants were all from medical institutions of pilot cities for the collaboration and integration of medical care and prevention. The study sample was selected through multi-stage sampling. A questionnaire based on the theoretical framework of the KAP model was designed. Two cross-sectional surveys were conducted-once before the initiation of the pilot program (baseline) and again 12 months after implementation (after implementation). After propensity score matching (PSM), descriptive statistics and hypothesis testing were used to statistically analyze the questionnaire data. In addition, a structural equation model (SEM) was applied to assess the current status and effect pathways of the participants' KAP regarding the integration of medical care and prevention.</p><p><strong>Results: </strong>A total of 11472 responses were collected, and 10627 were included in analysis after PSM, including 5007 before the implementation of the policy and 5620 after the implementation of the policy. No significant differences were observed in demographic variables between the two samples. Baseline scores for knowledge, attitude, and practice regarding the integration of medical care and prevention were 13.32 ± 0.05, 15.62 ± 0.04, and 6.37 ± 0.02 respectively, while the scores at the end of the study were 13.69, 15.74, and 6.51, respectively, all show an increase to a certain degree (<i>P</i> < 0.05). Stratified analysis by institution level revealed relatively significant improvements in knowledge and practice (<i>P</i> < 0.05), but no significant improvement in attitudes (<i>P</i> > 0.05) among medical professionals. Medical professionals in primary medical institutions generally demonstrated superior knowledge, attitudes, and practice frequency compared with those in secondary and tertiary hospitals (<i>P</i> < 0.001). No significant changes in KAP were observed among medical professionals in secondary hospitals (<i>P</i> > 0.05). Regarding the integration of medical care and prevention, the effect of knowledge on practice (standardized path coefficient = 0.496, 95% CI: 0.482, 0.508) was stronger than that of attitude on practice (standardized path coefficient = 0.267, 95% CI: 0.244, 0.290). The direct effect of knowledge on practice (78.0%) was greater than the indir
{"title":"[Current Status and Effect Pathways of Knowledge, Attitude, and Practice of Medical Care and Prevention Integration Among Medical Professionals].","authors":"Qiaosheng Li, Ting Wang, Weiyan Jian","doi":"10.12182/20251160104","DOIUrl":"10.12182/20251160104","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the changes in knowledge, attitude, and practice (KAP) regarding the integration of medical care and prevention among medical professionals in medical institutions of pilot cities of the collaboration and integration of medical care and prevention, a national pilot program for infectious disease prevention and control, to examine the effect pathways, and to provide empirical evidence for promoting the implementation of the integration of medical care and prevention and improving relevant policies.</p><p><strong>Methods: </strong>The participants in this study were medical professionals involved in medical care and prevention integration work. The participants were all from medical institutions of pilot cities for the collaboration and integration of medical care and prevention. The study sample was selected through multi-stage sampling. A questionnaire based on the theoretical framework of the KAP model was designed. Two cross-sectional surveys were conducted-once before the initiation of the pilot program (baseline) and again 12 months after implementation (after implementation). After propensity score matching (PSM), descriptive statistics and hypothesis testing were used to statistically analyze the questionnaire data. In addition, a structural equation model (SEM) was applied to assess the current status and effect pathways of the participants' KAP regarding the integration of medical care and prevention.</p><p><strong>Results: </strong>A total of 11472 responses were collected, and 10627 were included in analysis after PSM, including 5007 before the implementation of the policy and 5620 after the implementation of the policy. No significant differences were observed in demographic variables between the two samples. Baseline scores for knowledge, attitude, and practice regarding the integration of medical care and prevention were 13.32 ± 0.05, 15.62 ± 0.04, and 6.37 ± 0.02 respectively, while the scores at the end of the study were 13.69, 15.74, and 6.51, respectively, all show an increase to a certain degree (<i>P</i> < 0.05). Stratified analysis by institution level revealed relatively significant improvements in knowledge and practice (<i>P</i> < 0.05), but no significant improvement in attitudes (<i>P</i> > 0.05) among medical professionals. Medical professionals in primary medical institutions generally demonstrated superior knowledge, attitudes, and practice frequency compared with those in secondary and tertiary hospitals (<i>P</i> < 0.001). No significant changes in KAP were observed among medical professionals in secondary hospitals (<i>P</i> > 0.05). Regarding the integration of medical care and prevention, the effect of knowledge on practice (standardized path coefficient = 0.496, 95% CI: 0.482, 0.508) was stronger than that of attitude on practice (standardized path coefficient = 0.267, 95% CI: 0.244, 0.290). The direct effect of knowledge on practice (78.0%) was greater than the indir","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1498-1505"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yanyan Wang, Jiaqi Wang, Qiuhua Wei, Li Yu, Jin Shen
Test Methods for Disinfection Products (WS/T 10009-2023), a health industry standard, was officially released by the National Disease Control and Prevention Administration on December 15, 2023. The standard came into effect on May 1, 2024. This standard systematically specifies the testing and evaluation methods for disinfection products, covering three core components-disinfection effect testing and evaluation, physical and chemical testing techniques, and toxicological testing methods. The standard provides an important technical basis for the testing of disinfection products in China. To promote an accurate understanding and effective implementation of the standard, this article focuses on the in-depth interpretation of the section concerning the testing and evaluation methods of disinfection effects. It provides a detailed explanation of the major updates, technical highlights, and scientific rationale behind the standard. The article incorporates discussions on optimizing the validation test methods for the disinfection and sterilization effects of disinfectants, simulated field testing of disinfectants, evaluation of air disinfection effects, and the supplementation and improvement of testing methods for disinfection devices (including sterilization devices). This article aims to provide clear technical guidance for disinfection product inspection personnel, researchers, and other professionals involved, promote the standardized application of the standard, improve the quality of disinfection products, and ensure scientific, effective, and safe disinfection practices.
{"title":"[Interpretation of the Disinfection Effects Testing and Evaluation Methods Section in <i>Test Methods for Disinfection Products (WS/T 10009-2023)</i>].","authors":"Yanyan Wang, Jiaqi Wang, Qiuhua Wei, Li Yu, Jin Shen","doi":"10.12182/20250960102","DOIUrl":"10.12182/20250960102","url":null,"abstract":"<p><p><i>Test Methods for Disinfection Products (WS/T 10009-2023)</i>, a health industry standard, was officially released by the National Disease Control and Prevention Administration on December 15, 2023. The standard came into effect on May 1, 2024. This standard systematically specifies the testing and evaluation methods for disinfection products, covering three core components-disinfection effect testing and evaluation, physical and chemical testing techniques, and toxicological testing methods. The standard provides an important technical basis for the testing of disinfection products in China. To promote an accurate understanding and effective implementation of the standard, this article focuses on the in-depth interpretation of the section concerning the testing and evaluation methods of disinfection effects. It provides a detailed explanation of the major updates, technical highlights, and scientific rationale behind the standard. The article incorporates discussions on optimizing the validation test methods for the disinfection and sterilization effects of disinfectants, simulated field testing of disinfectants, evaluation of air disinfection effects, and the supplementation and improvement of testing methods for disinfection devices (including sterilization devices). This article aims to provide clear technical guidance for disinfection product inspection personnel, researchers, and other professionals involved, promote the standardized application of the standard, improve the quality of disinfection products, and ensure scientific, effective, and safe disinfection practices.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1184-1188"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
As global health challenges become increasingly complex and multidimensional, microbiome research and the One Health approach-along with their integration-actively promote the development of the field of public health laboratory sciences. The microbiome is an essential component of the human body, animals, and the environment. Microbiome research not only elucidates the interaction mechanisms between microorganisms and their hosts but also provides an irreplaceable material basis for the well-being of humans, animals, and the environment, offering new perspectives for the prevention, diagnosis, and treatment of human diseases. Additionally, the One Health approach emphasizes the interconnectedness of human, animal, and environmental health, establishing a theoretical foundation for interdisciplinary collaboration and global health management. The integration of the microbiome and the One Health approach establishes the notion of "the balance of dynamic factors" as a scientific principle underpinning One Health. This integration holds far-reaching implications for expanding new fields and developing new technologies in public health laboratory sciences, as well as informing public health practices.
{"title":"[Integration of Microbiome Research and the One Health Approach Promotes Innovation and Development in Public Health Laboratory Sciences].","authors":"Ruifu Yang","doi":"10.12182/20250960601","DOIUrl":"10.12182/20250960601","url":null,"abstract":"<p><p>As global health challenges become increasingly complex and multidimensional, microbiome research and the One Health approach-along with their integration-actively promote the development of the field of public health laboratory sciences. The microbiome is an essential component of the human body, animals, and the environment. Microbiome research not only elucidates the interaction mechanisms between microorganisms and their hosts but also provides an irreplaceable material basis for the well-being of humans, animals, and the environment, offering new perspectives for the prevention, diagnosis, and treatment of human diseases. Additionally, the One Health approach emphasizes the interconnectedness of human, animal, and environmental health, establishing a theoretical foundation for interdisciplinary collaboration and global health management. The integration of the microbiome and the One Health approach establishes the notion of \"the balance of dynamic factors\" as a scientific principle underpinning One Health. This integration holds far-reaching implications for expanding new fields and developing new technologies in public health laboratory sciences, as well as informing public health practices.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1171-1176"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kai Wang, Qixun Nian, Chunmin Wang, Qiuping Zhang, Qian Xu
Objective: To develop a novel solid-phase extraction (SPE) method based on a functionalized nanofiber membrane for the efficient co-extraction of structurally diverse antibiotics with markedly different physicochemical properties from source water, and to establish a high-throughput analysis method by coupling this technique with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
Methods: A polydopamine and zirconium (Ⅳ) fumarate metal-organic frameworks (MOF-801) co-modified polyacrylonitrile nanofiber membrane (PDA@PAN/MOF-801 NFMs) was prepared as the SPE adsorbent through hybrid electrospinning and dopamine self-polymerization. Critical SPE and UPLC-MS/MS parameters were optimized, and the method was applied to analyze antibiotic contamination in source water samples from 14 sources of centralized drinking water supply in Suzhou, China, to evaluate the practical application potential of the method.
Results: The PDA@PAN/MOF-801 NFMs adsorbent demonstrated efficient adsorption of 32 antibiotics from 6 classes through multiple retention mechanisms, including synergistic electrostatic interactions, hydrogen bonding, and π-π interactions. In combination with UPLC-MS/MS, the SPE method we developed enabled high-throughput detection of multiple antibiotics in source water, with limits of detection (LOD) being 0.001-0.05 ng/L and limits of quantitation (LOQ) being 0.005-500 ng/L. Spiked recoveries were 70.14%-111.50%. Intra-day relative standard deviation (RSD) was below 14.12% and the inter-day RSD was below 15.07%. The method demonstrated excellent sensitivity, accuracy, and precision.
Conclusion: In this study, we successfully developed an efficient analytical method based on a novel nanofiber membrane adsorbent. This approach provides a new technical reference for the high-throughput detection of multiple antibiotics in environmental waters and shows promising potential for practical applications.
{"title":"[High-Throughput Detection of Multiple Classes of Antibiotics in Source Water Using a Functionalized Polyacrylonitrile Nanofiber Membrane].","authors":"Kai Wang, Qixun Nian, Chunmin Wang, Qiuping Zhang, Qian Xu","doi":"10.12182/20250960105","DOIUrl":"10.12182/20250960105","url":null,"abstract":"<p><strong>Objective: </strong>To develop a novel solid-phase extraction (SPE) method based on a functionalized nanofiber membrane for the efficient co-extraction of structurally diverse antibiotics with markedly different physicochemical properties from source water, and to establish a high-throughput analysis method by coupling this technique with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).</p><p><strong>Methods: </strong>A polydopamine and zirconium (Ⅳ) fumarate metal-organic frameworks (MOF-801) co-modified polyacrylonitrile nanofiber membrane (PDA@PAN/MOF-801 NFMs) was prepared as the SPE adsorbent through hybrid electrospinning and dopamine self-polymerization. Critical SPE and UPLC-MS/MS parameters were optimized, and the method was applied to analyze antibiotic contamination in source water samples from 14 sources of centralized drinking water supply in Suzhou, China, to evaluate the practical application potential of the method.</p><p><strong>Results: </strong>The PDA@PAN/MOF-801 NFMs adsorbent demonstrated efficient adsorption of 32 antibiotics from 6 classes through multiple retention mechanisms, including synergistic electrostatic interactions, hydrogen bonding, and π-π interactions. In combination with UPLC-MS/MS, the SPE method we developed enabled high-throughput detection of multiple antibiotics in source water, with limits of detection (LOD) being 0.001-0.05 ng/L and limits of quantitation (LOQ) being 0.005-500 ng/L. Spiked recoveries were 70.14%-111.50%. Intra-day relative standard deviation (RSD) was below 14.12% and the inter-day RSD was below 15.07%. The method demonstrated excellent sensitivity, accuracy, and precision.</p><p><strong>Conclusion: </strong>In this study, we successfully developed an efficient analytical method based on a novel nanofiber membrane adsorbent. This approach provides a new technical reference for the high-throughput detection of multiple antibiotics in environmental waters and shows promising potential for practical applications.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1197-1207"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}